THERAPEUTIC AGENTS
    1.
    发明申请
    THERAPEUTIC AGENTS 有权
    治疗药剂

    公开(公告)号:US20150258048A1

    公开(公告)日:2015-09-17

    申请号:US14725732

    申请日:2015-05-29

    申请人: Allergan, Inc.

    发明人: David W. Old

    IPC分类号: A61K31/192 A61K31/381

    摘要: The invention provides well-defined compounds that are either EP2 agonists, EP4 agonists, or mixed EP2/EP4 agonist. The compounds are useful for treating a variety of pathological conditions associated with activity of the EP2 and/or EP4 receptors.

    摘要翻译: 本发明提供了明确定义的化合物,其是EP2激动剂,EP4激动剂或混合EP2 / EP4激动剂。 该化合物可用于治疗与EP2和/或EP4受体的活性相关的各种病理状况。

    Therapeutic agents
    2.
    发明授权
    Therapeutic agents 有权
    治疗剂

    公开(公告)号:US09051294B2

    公开(公告)日:2015-06-09

    申请号:US14264144

    申请日:2014-04-29

    申请人: Allergan, Inc.

    发明人: David W. Old

    摘要: The invention provides well-defined compounds that are either EP2 agonists, EP4 agonists, or mixed EP2/EP4 agonist. The compounds are useful for treating a variety of pathological conditions associated with activity of the EP2 and/or EP4 receptors.

    摘要翻译: 本发明提供了明确定义的化合物,其是EP2激动剂,EP4激动剂或混合EP2 / EP4激动剂。 该化合物可用于治疗与EP2和/或EP4受体的活性相关的各种病理状况。

    Loxoprofen derivative and pharmaceutical preparation containing the same
    3.
    发明授权
    Loxoprofen derivative and pharmaceutical preparation containing the same 有权
    洛索丙芬衍生物和含有它的药物制剂

    公开(公告)号:US08431614B2

    公开(公告)日:2013-04-30

    申请号:US13148566

    申请日:2010-02-18

    摘要: There is provided a novel loxoprofen derivative that has no side effect such as a gastrointestinal disorder and also has excellent anti-inflammatory and analgesic effects and is represented by the following formula (I) or (II): (wherein R1 and R2 each represent a halogen atom or a substituted or unsubstituted phenyl group) or a pharmacologically acceptable salt thereof. In the derivative, the halogen atom is selected from a chlorine atom, a bromine atom, a fluorine atom, and an iodine atom, and a substituent of the substituted phenyl group is a halogen atom, a hydroxyl group, a substituted or unsubstituted lower alkyl group, a lower alkylthio group, a lower alkoxy group, a nitro group, an amino group, or a carboxyl group.

    摘要翻译: 本发明提供一种新颖的洛索洛芬衍生物,其不具有胃肠功能紊乱等副作用,具有优异的抗炎镇痛效果,并且由下式(I)或(II)表示:(其中R1和R2各自表示 卤素原子或取代或未取代的苯基)或其药理学上可接受的盐。 在衍生物中,卤素原子选自氯原子,溴原子,氟原子和碘原子,取代苯基的取代基为卤素原子,羟基,取代或未取代的低级烷基 低级烷硫基,低级烷氧基,硝基,氨基或羧基。